Has Prasanna Chinthala, MD received payments from drug or device companies?

Yes. Drug and device makers reported $686 in general payments to Prasanna Chinthala, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Prasanna Chinthala, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Prasanna Chinthala, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Prasanna Chinthala, MD

Psychiatry · Carmel, INNPI 1902913718

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 25.9% of the total. Reporting peaked in 2023 at $354 and has fallen 84.8% since, to $54 in 2025.

$686in general payments, 2019–2025

Across 24 payments — averaging $28.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$177
Indivior Inc.$130
Sun Pharmaceutical Industries Inc.$116
Bioxcel Therapeutics, Inc.$87
AbbVie$67
Teva Pharmaceuticals USA, Inc.$32
plus $77 from 4 others

$45,069in research payments, 2019–2025

Across 26 payments — averaging $1733.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Livanova USA, Inc.$45K

What the payments were for

Food & beverage$686100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	5	$177
Indivior Inc.	2	$130
Sun Pharmaceutical Industries Inc.	2	$116
Bioxcel Therapeutics, Inc.	4	$87
AbbVie(2 entities)	4	$67
Teva Pharmaceuticals USA, Inc.	2	$32
Noven Therapeutics, LLC	2	$29
Axsome Therapeutics, Inc.	1	$18
Lundbeck LLC	1	$16
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ABILIFY ASIMTUFII$125
ABILIFY MAINTENA$125

How this compares

$686 in reported general payments places this provider in the 60th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana →

Medicare billing

Part B allowed, 2024

$64,970

Medicare patients

254

Services billed

765

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Medroxyprogesterone Acetate	70	$13,520
Aripiprazole	26	$5,300
Duloxetine Hcl	85	$3,209
Divalproex Sodium	42	$3,143
Memantine Hcl	27	$2,863
Mirtazapine	81	$2,791
Gabapentin	68	$2,550
Olanzapine	44	$2,128
Fluvoxamine Maleate	31	$2,087
Sertraline Hcl	109	$1,860
Escitalopram Oxalate	79	$1,749
AmantadineAmantadine Hcl	24	$1,488
Lamotrigine	44	$1,222
Risperidone	80	$1,189
Buspirone Hcl	55	$1,111

Paid to pharmacies, not to this prescriber.

Other psychiatry in Carmel

Steven PaulCarmel$2.9M
Christopher BojrabCarmel$713K
Michael DetkeCarmel$14K
Michael WebberCarmel$9K
Tyler FlaninghamCarmel$7K
Jay FawverAngola$1.4M
Suhayl NasrMichigan City$739K
Joseph FanelliMunster$443K
Eric JaggersJeffersonville$260K
Larry LambertsonFort Wayne$208K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →